Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks

CNS Drug Reviews

Volumn 11, Issue 1, 2005, Pages 69-76

  Edvinsson, Lars ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BIBN4096BS; CGRP antagonists; Migraine

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE ANTAGONIST; OLCEGEPANT; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; CLINICAL TRIAL; CLUSTER HEADACHE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FLUSHING; HEADACHE; HEAT; HUMAN; MIGRAINE; NAUSEA; PARESTHESIA; REVIEW; SENSORY NERVE CELL; SIDE EFFECT; VISUAL DISORDER; XEROSTOMIA;

EID: 17744373464     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2005.tb00036.x     Document Type: Review

References (32)

1. Baskaya MK, Suzuki Y, Anzai M, et al. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J Cereb Blood Flow Metab 1995;15:827-834.
2. Brain SD. Calcitonin gene-related peptide (CGRP) antagonists: Blockers of neuronal transmission in migraine. Br J Pharmacol 2004;142:1053-1054.
3. Dodick DW. Introduction: Cardiovascular safety and triptans in the acute treatment of migraine. Headache 2004;44(Suppl 1):S1-S4.
4. Doods H, Hallenmayer G, Wu D, et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000;129:420-423.
5. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: A new target in the treatment of headache. Cephalalgia 2004;24:611-622.
6. Edvinsson L, Alm R, Shaw D, et al. Effect of the CGRP receptor antagonist BIBN4096Bs in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 2002;434:49-53.
7. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Rev 2005;48: In press.
8. Farachi FM, Kadel KA, Heistad DD. Vascular responses of dura mater. Am J Physiol 1989;257:H157-161.
9. 1B/1D agonist) in acute migraine treatment: A meta-analysis of 52 trials. Lancet 2001;358:1668-1675.
10. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine. Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
11. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187.
12. Gulbenkian S, Uddman R, Edvinsson L. Neuronal messengers in the human cerebral circulation. Peptides 2001;22:995-1007.
13. Harper M, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol 1984;246:H17-24.
14. Howden CW, Logue C, Gavin K, et al. Haemodynamic effects of intravenous human calcitonin-gene related peptide in man. Clin Sci 1988;74:413-418.
15. Iovino M, Feifel U, Yong C-L, et al. Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers. Cephalalgia 2004;24:645-656.
16. Juhasz G, Zsombok T, Jakab B, et al. Parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache after sumatriptan treatment. Cephalalgia 2005;25:1-2.
17. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003;106:461-470.
18. Lassen LH, Haderslev PA, Jacobsen VB, et al. CGRP may play a causative role in migraine. Cephalalgia 2002;22:54-61.
19. Lind H, Edvinsson L. Enhanced vasodilator responses to calcitonin gene-related peptide (CGRP) in subcutaneous arteries in human hypertension. J Human Hypertens 2002;16:53-59.
20. MassenVanDenBrink A, Saxena P. Coronary vasoconstrictor potential of triptans: A review of in vitro pharmacologic data. Headache 2004;44(Suppl 1):S13-S19.
21. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med 2004;350:1073-1075.
22. Oliver KR, Wainwright A, Edvinsson L, et al. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002;22:620-629.
23. Petersen KA, Birk S, Lassen LH, et al. The novel CGRP-antagonist, BIBN4096BS does not affect the cerebral hemodynamics in healthy volunteers. Cephalalgia 2003;23:729.
24. Petersen KA, Lassen LH, Birk S, et al. The effect of the nonpeptide CGRP-antagonist, BIBN4096BS on human-alphaBGRP induced headache and hemodynamics in healthy volunteers. Cephalalgia 2003;23:725.
25. Petersen KA, Schindler M, Doods H, et al. Inhibiting effect of BIBN4096BS on cephalic vasodilatation induced by CGRP and electrical stimulation of dura mater in the rat. Br J Pharmacol 2004;143:697-704.
26. Ray BS, Wolff HG. Experimental studies on headaches, pain sensitive structures of the head and their significance in headache. Arch Surg 1940;41:813-56.
27. Roon KI, Olesen J, Diener HC, et al. No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials. Ann Neurol 2000;47:238-41
28. Struthers AD, Brown MJ, Macdonald DW, et al. Human calcitonin gene related peptide: A potent endogenous vasodilator in man. Clin Sci 1986;70:386-393.
29. Suzuki Y, Satoh S, Ikegaki I, et al. Effects of neuropeptide Y and calcitonin gene-related peptide on local cerebral blood flow in rat striatum. J Cereb Blood Flow Metab 1989;9:268-270.
30. The International Classification of Headache Disorders. Cephalalgia 2004;24(Suppl 1):1-160.
31. Williamson DJ, Hargreaves RJ, Hill RG, et al. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat - intravital microscope studies. Cephalalgia 1997;17:525-531.
32. Wu D, Eberlein W, Rudolf K, et al. Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: Evidence for a [Cys(Et)(2,7)]hCGRP-preferring receptor Eur J Pharmacol 2000;400:313-319.